Clinical Trials in Colorado

Showing 13721-13740 of 18,143 trials

YouScript IMPACT Registry

NCT02191358

This multicenter observational study aims to investigate the benefits of providing pharmacogenetic testing with the YouScript Personalized Prescribing System which includes a clinical decision support tool and individualized pharmacist recommendations to elderly polypharmacy patients who are most at risk of adverse drug events. The YouScript system is unique in identifying drug-gene, and drug-drug-gene interactions that are missed by existing systems, and represent over 35% of significant interaction warnings. Data analysis will assess the impact of recommendations for medication changes on clinical decision making, patient outcomes, and healthcare resource utilization to determine which medications, specialties, or patient segments derive the greatest benefit from this intervention. Data gathered from patients enrolled in this study will be compared to patients matched on key characteristics from Inovalon's MORE2 healthcare database.

Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more

Genelex Corporation800 participantsStarted Oct 2014

Garden Grove, California, United States • Denver, Colorado, United States • Lexington, Kentucky, United States +4 more locations

COMPLETED53 miles

Factors Affecting PrEP Adherence

NCT02411630

The purpose of this study is to test a new way to take a questionnaire that asks about adherence (whether the person is taking the medicine correctly). This new questionnaire is called Interactive Questionnaire System (iQS). In this study, the iQS will be tested on HIV-negative young men who have sex with men (YMSM) who are taking PrEP as part of another study, either ATN 110 or ATN 113.

HIV Infection

University of North Carolina, Chapel Hill167 participantsStarted Jun 2013

Los Angeles, California, United States • Aurora, Colorado, United States • Miami, Florida, United States +9 more locations

YouScript IMPACT Registry

Factors Affecting PrEP Adherence

Find Trials by Condition in Colorado

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

Managerial Database II

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Cancer & Chemotherapy Symptom Management Using an Automated Telephone Reporting System

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

EPO906 in Carcinoid and Other Neuroendocrine Tumors

A Novel Method to Determine HIV Incidence Among Youth

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

CDC-ATN Linkage Evaluation

Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Treatment De-Intensification and Residual HIV-1 in Youth

Immunologic Memory (Supp. of ATN 024)